Ritten secures a $35 million Series B investment led by Five Elms Capital to expand its AI-driven behavioral health management platform.
Target Information
Ritten is an innovative AI-powered behavioral health management platform founded in 2020 and headquartered in Philadelphia, Pennsylvania. The company specializes in providing a unified system of record for behavioral health practitioners, encompassing electronic medical records (EMR), customer relationship management (CRM), and revenue cycle management (RCM) into a single, cohesive platform. This integration allows treatment providers to streamline operations, ensuring they can focus on delivering high-quality care while effectively managing their administrative tasks.
With a firm commitment to enhancing the quality of care in the behavioral health sector, Ritten serves a diverse range of clients — from single-site facilities to multi-state enterprises. Its platform is designed to support mental health and addiction treatment providers at all levels of care, addressing crucial operational needs and alleviating the burdens faced by clinical staff.
Access Full Deal Insights
You’re viewing a public preview of this deal. To unlock full access to ca. 50,000 other deals in our database and join ca. 400 M&A professionals who are using it daily, sign up for Dealert.
Industry Overview
The behavioral health industry in the United States is undergoing significant transformation, driven by an increasing demand for mental health and addiction services. As societal awareness of mental health issues grows, more individuals are seeking tr
Similar Deals
Redpoint Ventures → Function Health
2025
ARCH Venture Partners, GV (Google Ventures) → Pelage Pharmaceuticals
2025
Goldman Sachs Alternatives → evolvedMD
2025
EQT Life Sciences, Sanofi Ventures → SpliceBio
2025
Blue Owl Capital → Latigo Biotherapeutics
2025
Five Elms Capital
invested in
Ritten
in 2025
in a Series B deal
Disclosed details
Transaction Size: $35M